Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Efficacy and Safety of SDN-037

ClinicalTrials.gov ID: NCT03426267

Public ClinicalTrials.gov record NCT03426267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:52 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Parallel Group, Multicenter, Study To Evaluate Efficacy And Safety of SDN -037 Twice Daily Compared With Vehicle For The Treatment Of Inflammation And Pain Associated With Ocular Surgery.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.

Study identification

NCT ID
NCT03426267
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
325 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2018 (Actual)
Primary completion
Mar 5, 2020 (Actual)
Completion
Mar 5, 2020 (Actual)
Last update posted
May 17, 2021

2018 – 2020

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
SPARC Site 13 Chandler Arizona 85224 —
SPARC Site 14 Mesa Arizona 85208 —
SPARC Site 11 Prescott Arizona 86301 —
SPARC Site 12 Sun City Arizona 85351 —
SPARC site 01 Fayetteville Arkansas 72704 —
SPARC Site 10 Santa Barbara California 93110 —
SPARC Site 08 Colorado Springs Colorado 80919 —
SPARC Site 06 Coral Springs Florida 33067 —
SPARC Site 18 Fort Myers Florida 33901 —
SPARC Site 16 Jacksonville Florida 32204 —
SPARC Site 07 Miami Florida 33143 —
SPARC Site 15 Paducah Kentucky 42001 —
SPARC Site 05 Saint Joseph Michigan 49085 —
SPARC Site 09 Henderson Nevada 89052 —
SPARC Site 03 Poughkeepsie New York 12603 —
SPARC Site 04 Winston-Salem North Carolina 27101 —
SPARC Site 17 Fargo North Dakota 58103 —
SPARC Site 19 Austin Texas 78731 —
SPARC Site 2 Mission Texas 78572 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03426267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2021 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03426267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →